Cite
HARVARD Citation
Bouabdallaoui, N. et al. (2018). Growth differentiation factor‐15 is not modified by sacubitril/valsartan and is an independent marker of risk in patients with heart failure and reduced ejection fraction: the PARADIGM‐HF trial. European journal of heart failure. pp. 1701-1709. [Online].